These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22613149)

  • 1. Development of [(18)F]-PSS223 as a PET tracer for imaging of metabotropic glutamate receptor subtype 5 (mGluR5).
    Sephton SM; Dennler P; Leutwiler DS; Mu L; Schibli R; Krämer SD; Ametamey SM
    Chimia (Aarau); 2012; 66(4):201-4. PubMed ID: 22613149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo evaluation of [18F]-FDEGPECO as a PET tracer for imaging the metabotropic glutamate receptor subtype 5 (mGluR5).
    Wanger-Baumann CA; Mu L; Honer M; Belli S; Alf MF; Schubiger PA; Krämer SD; Ametamey SM
    Neuroimage; 2011 Jun; 56(3):984-91. PubMed ID: 21406237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, radiolabeling, in vitro and in vivo evaluation of [18F]-FPECMO as a positron emission tomography radioligand for imaging the metabotropic glutamate receptor subtype 5.
    Lucatelli C; Honer M; Salazar JF; Ross TL; Schubiger PA; Ametamey SM
    Nucl Med Biol; 2009 Aug; 36(6):613-22. PubMed ID: 19647167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of fluorinated (E)-3-((6-methylpyridin-2-yl)ethynyl)cyclohex-2-enone-O-methyloxime (ABP688) derivatives and the discovery of a high affinity analogue as a potential candidate for imaging metabotropic glutamate recepors subtype 5 (mGluR5) with positron emission tomography (PET).
    Baumann CA; Mu L; Johannsen S; Honer M; Schubiger PA; Ametamey SM
    J Med Chem; 2010 May; 53(10):4009-17. PubMed ID: 20411954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5.
    Ametamey SM; Kessler LJ; Honer M; Wyss MT; Buck A; Hintermann S; Auberson YP; Gasparini F; Schubiger PA
    J Nucl Med; 2006 Apr; 47(4):698-705. PubMed ID: 16595505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human PET studies of metabotropic glutamate receptor subtype 5 with 11C-ABP688.
    Ametamey SM; Treyer V; Streffer J; Wyss MT; Schmidt M; Blagoev M; Hintermann S; Auberson Y; Gasparini F; Fischer UC; Buck A
    J Nucl Med; 2007 Feb; 48(2):247-52. PubMed ID: 17268022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiolabeling and in vitro and in vivo evaluation of [18F]-FE-DABP688 as a PET radioligand for the metabotropic glutamate receptor subtype 5.
    Honer M; Stoffel A; Kessler LJ; Schubiger PA; Ametamey SM
    Nucl Med Biol; 2007 Nov; 34(8):973-80. PubMed ID: 17998101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of novel α-fluorinated (E)-3-((6-methylpyridin-2-yl)ethynyl)cyclohex-2-enone-O-methyl oxime (ABP688) derivatives as metabotropic glutamate receptor subtype 5 PET radiotracers.
    Milicevic Sephton S; Mu L; Schweizer WB; Schibli R; Krämer SD; Ametamey SM
    J Med Chem; 2012 Aug; 55(16):7154-62. PubMed ID: 22822714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, radiolabelling and in vitro and in vivo evaluation of a novel fluorinated ABP688 derivative for the PET imaging of metabotropic glutamate receptor subtype 5.
    Sephton SM; Dennler P; Leutwiler DS; Mu L; Wanger-Baumann CA; Schibli R; Krämer SD; Ametamey SM
    Am J Nucl Med Mol Imaging; 2012; 2(1):14-28. PubMed ID: 23133799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo variation in metabotropic glutamate receptor subtype 5 binding using positron emission tomography and [11C]ABP688.
    DeLorenzo C; Kumar JS; Mann JJ; Parsey RV
    J Cereb Blood Flow Metab; 2011 Nov; 31(11):2169-80. PubMed ID: 21792244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding potential of (E)-[¹¹C]ABP688 to metabotropic glutamate receptor subtype 5 is decreased by the inclusion of its ¹¹C-labelled Z-isomer.
    Kawamura K; Yamasaki T; Kumata K; Furutsuka K; Takei M; Wakizaka H; Fujinaga M; Kariya K; Yui J; Hatori A; Xie L; Shimoda Y; Hashimoto H; Hayashi K; Zhang MR
    Nucl Med Biol; 2014 Jan; 41(1):17-23. PubMed ID: 24183615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syntheses and pharmacological characterization of novel thiazole derivatives as potential mGluR5 PET ligands.
    Baumann CA; Mu L; Wertli N; Krämer SD; Honer M; Schubiger PA; Ametamey SM
    Bioorg Med Chem; 2010 Aug; 18(16):6044-54. PubMed ID: 20634080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and preliminary biological evaluation of 3-[(18)F]fluoro-5-(2-pyridinylethynyl)benzonitrile as a PET radiotracer for imaging metabotropic glutamate receptor subtype 5.
    Wang JQ; Tueckmantel W; Zhu A; Pellegrino D; Brownell AL
    Synapse; 2007 Dec; 61(12):951-61. PubMed ID: 17787003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, evaluation, and radiolabeling of new potent positive allosteric modulators of the metabotropic glutamate receptor 2 as potential tracers for positron emission tomography imaging.
    Andrés JI; Alcázar J; Cid JM; De Angelis M; Iturrino L; Langlois X; Lavreysen H; Trabanco AA; Celen S; Bormans G
    J Med Chem; 2012 Oct; 55(20):8685-99. PubMed ID: 22992024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo evaluation of [11C]MPEPy as a potential PET ligand for mGlu5 receptors.
    Severance AJ; Parsey RV; Kumar JS; Underwood MD; Arango V; Majo VJ; Prabhakaran J; Simpson NR; Van Heertum RL; Mann JJ
    Nucl Med Biol; 2006 Nov; 33(8):1021-7. PubMed ID: 17127176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo positron emission tomography imaging with [¹¹C]ABP688: binding variability and specificity for the metabotropic glutamate receptor subtype 5 in baboons.
    DeLorenzo C; Milak MS; Brennan KG; Kumar JS; Mann JJ; Parsey RV
    Eur J Nucl Med Mol Imaging; 2011 Jun; 38(6):1083-94. PubMed ID: 21279350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical anaylses of [
    Lee B; Kim YK; Lee JY; Kim YJ; Lee YS; Lee DS; Chung JK; Jeong JM
    J Cereb Blood Flow Metab; 2017 Jun; 37(6):2283-2293. PubMed ID: 27501957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute Ketamine Infusion in Rat Does Not Affect In Vivo [
    Kosten L; Verhaeghe J; Wyffels L; Stroobants S; Staelens S
    Mol Imaging; 2018; 17():1536012118788636. PubMed ID: 30213221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetylcysteine- and MK-801-induced changes in glutamate levels do not affect in vivo binding of metabotropic glutamate 5 receptor radioligand 11C-ABP688 in rat brain.
    Wyckhuys T; Verhaeghe J; Wyffels L; Langlois X; Schmidt M; Stroobants S; Staelens S
    J Nucl Med; 2013 Nov; 54(11):1954-61. PubMed ID: 24050937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative evaluation of 11C-ABP688 as PET ligand for the measurement of the metabotropic glutamate receptor subtype 5 using autoradiographic studies and a beta-scintillator.
    Wyss MT; Ametamey SM; Treyer V; Bettio A; Blagoev M; Kessler LJ; Burger C; Weber B; Schmidt M; Gasparini F; Buck A
    Neuroimage; 2007 Apr; 35(3):1086-92. PubMed ID: 17320417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.